Atorvastatin 134523-03-8
-
- Category :
Pharmaceuticals and Biochemicals/Cardiovascular agents
- CAS NO : 134523-03-8
- EC NO :
- Molecular Formula : C66H68Ca2F2N4O10
- Main Specifications : Atorvastatin 134523-03-8
- Synonyms : ATORVASTATIN CA;[r-(r*, r*)]-7-[2-(4-fluorophenyl)-5-(1-methylethyl)-3-phenyl-4-(phenylaminocarbonyl)-1h-pyrrol-1-yl]-3,5-dihydroxy-heptanoic acid calcium salt;1h-pyrrole-1-heptanoicacid,beta,delta-dihydroxy-2-(4-fluorophenyl)-5-(1-methy calciumsalt(2:1),(r-(r*,r*))-lethyl)-3-phenyl-4-((phenylamino)carbonyl);delta-dihydroxy-2-(4-fluorophenyl)-5-(1-methylethyl)-3-phenyl-4-((phenylamino)carbonyl)-betcalci1h-pyrrole-1-heptanoicaci;pd134298-38a;ATORVASTATINCALCUIM;calcium (3R,5R)-7-[2-(4-fluorophenyl)-3-phenyl-4-(phenylcarbamoyl)-5-p ropan-2-yl-pyrrol-1-yl]-3,5-dihydroxy-heptanoate;1H-Pyrrole-1-heptanoic acid, 2-(4-fluorophenyl)-beta,delta-dihydroxy-5-(1-methylethyl)-3-phenyl-4-((phenylamino)carbonyl)-calcium salt (2: 1), (R-(R*,R*))-;1H-Pyrrole-1-heptanoic acid,beta,delta-dihydroxy-2-(4-fluorophenyl)-5-(1-methylethyl)-3-phenyl-4-((phenylamino)carbonyl)-calcium salt (2: 1);(R-(R*,R*))-, Atorvastatin calcium;Atorvastatin calcium (USAN);Atorvastatin calcium salt;Atorvastatin calcium [USAN];C08078;Calcium (betaR,deltaR)-2-(p-fluorophenyl)-beta,delta-dihydroxy-5-isopr opyl-3-phenyl-4-(phenylcarbamoyl)pyrrole-1-heptanoate (1:2);CI-981;D00887;DRG-0321;Lipibec;Lipitor;Lipitor (TN);LS-136974;PD 134298-38A;Prevencor;Sortis;Tahor;Torvast;YM-548;Atorvastatin Calsium;(3R,5R)-7-[2-(4-Fluorophenyl)-5-Isopropyl-3-Phenyl-4-(Pheynylcarbamoyl)Pyrrol-1-yl]-3,5-Dihydroheptanoic Acid,calcium salt;(3R,5R)-7-[2-(4-Fluorophenyl)-5-Isopropyl-3-Phenyl-4-(Pheynylcarbamoyl)Pyrrol-1-yl]-3,5¨CDihydroheptanoic Acid,calcium salt;L-4;(3R,5R)-7-[2-(4-Fluorophenyl)-5-Isopropyl-3-Phenyl-4-(Pheynylcarbamoyl)Pyrrol-1-yl]-3,5¨CDihydroheptanoic Acid,calcium salt(L-4);beta,delta-dihydroxy-2-(4-fluorophenyl)-5-(1-methylethyl)-3-phenyl-4-((phenylamino)carbonyl)-calcium salt(2:1);Atorvastatin Calcium Anhydrous;
Package: 10kg/drum
Uses : Antilipemic agent
Molecular Structure:
Product description:
Product Name:atorvastatin calcium amorphous / crystalline
Other names: Lipitor, Atorvastatin, Atorvastatin Ca, Atorvastatin calcium, Atarvadel
Category: pharmaceutical raw material bulk drugs api
Cas.No.: 134523-03-8
M.F.: C66H68CaF2N4O10.3H2O
Qaulity Standard: YBH00062011
Edition: CP
Applicable category: Antilipemic agent
Finished dosage: Atorvastatin calcium tablet
Appearance: white or almost white powder, odourless, tasteless, slightly hygroscopicity;
Freely soluble in methanol,very slightly soluble in chloroform,not soluble in water,ethyl acetate,aether and cyclohexane;
Assay: 98% - 102%,on the anhydrous basis;
Loss on drying: 3%~6%
Specific rotation: -9°~-7°
Related impurities: total impurities ≤1%; individual impurity≤0.3%;
Heavy metal: ≤ 20 PPM
Packing: 10 kg/drum
Advantage: High purity, Low heavy metal, Low related impurities, GMP certificate, Profession
Activity & Sevice: pharmaceuticals looking for distributors, wholesale pharmaceutical generic drugs, provide lab testing service pharmaceutical
Product Introduction: Atorvastatin Calcium is a member of the drug class known as statins, used for lowering blood cholesterol. It also stabilizes plaque and prevents strokes through anti-inflammatory and other mechanisms. Like all statins, atorvastatin works by inhibiting HMG-CoA reductase, an enzyme found in liver tissue that plays a key role in production of cholesterol in the body.
Atorvastatin was first synthesized in 1985 by Bruce Roth while working at Parke-Davis Warner-Lambert Company (now Pfizer). With 2008 sales of US$12.4 billion, Lipitor was the top-selling branded pharmaceutical in the world. U.S. patent protection was scheduled to expire in June 2011.